EverSource Wealth Advisors LLC Has $141,000 Stock Holdings in Sanofi (NASDAQ:SNY)

EverSource Wealth Advisors LLC reduced its stake in shares of Sanofi (NASDAQ:SNY) by 29.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,917 shares of the company’s stock after selling 1,227 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Sanofi were worth $141,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Synergy Asset Management LLC bought a new stake in Sanofi during the fourth quarter worth $25,000. McClarren Financial Advisors Inc. lifted its position in shares of Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after buying an additional 543 shares during the last quarter. Sunbelt Securities Inc. boosted its stake in Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after buying an additional 313 shares in the last quarter. Sierra Ocean LLC bought a new position in Sanofi in the fourth quarter valued at about $44,000. Finally, Versant Capital Management Inc acquired a new position in Sanofi during the fourth quarter worth about $54,000. Institutional investors own 14.04% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $60.00.

Sanofi Stock Performance

Sanofi stock opened at $58.92 on Tuesday. The business has a 50 day moving average of $53.85 and a 200-day moving average of $52.83. The company has a market capitalization of $149.53 billion, a P/E ratio of 23.66, a P/E/G ratio of 1.01 and a beta of 0.58. Sanofi has a 1 year low of $45.22 and a 1 year high of $60.12. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 1.14.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities research analysts predict that Sanofi will post 4.36 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.